To stop the body from rejecting a transplanted organ, such as a kidney, heart, or liver, Ipca MMF-S Tablet is utilised. When the recipient’s immune system attacks the transplanted organ because it perceives it as a “foreign object,” transplant rejection takes place. It could result in irreparable harm if treatment is delayed.
In addition to an additional immunosuppressive and anti-inflammatory drug, Ipca MMF-S Tablet contains “Mycophenolate sodium,” which is used to treat organ transplant rejection. It reduces the formation of antibodies (which recognise and eliminate foreign cells) and T and B lymphocytes (white blood cells that fight foreign cells). In order to prevent the transplanted graft from being rejected, these actions inhibit the immune system.
As long as your doctor has recommended Ipca MMF-S Tablet, take it. You could occasionally encounter typical side effects like fever, respiratory infections, low blood pressure, coughing, muscle soreness, and diarrhoea. The majority of these side effects go away on their own with time and don’t need medical intervention. However, if these side effects become persistent, you should consult your physician.
Continue using Ipca MMF-S Tablets as directed by your doctor for the duration necessary to effectively treat your disease. Avoid stopping it in the middle to prevent reoccurring symptoms. If you are pregnant or intend to become pregnant, avoid taking Ipca MMF-S Tablet. Breastfeeding moms shouldn’t use Ipca MMF-S Tablet since it gets into their breast milk. Children shouldn’t be given Ipca MMF-S Tablets since its safety and effectiveness have not been shown. Ipca MMF-S Tablet may increase your risk of infection, therefore if you experience fever, sore throat, dyspnoea, jaundice, unexplained bleeding, or bruises, see your doctor. Wear protective clothes, use high-protection factor sunscreen, and avoid prolonged exposure to sunlight when using the Ipca MMF-S Tablet.
Prevent organ transplant rejection with treatment.
As prescribed by the physician, take it. Drink a glass of water and swallow it whole. Avoid chewing, crushing, or breaking it.
• Dizziness
• Headache
• Cough
• Respiratory infections
• Weakness (asthenia)
• Muscle pain (myalgia)
• Shortness of breath (dyspnoea)
Mycophenolate sodium, an ingredient in Ipca MMF-S Tablet, is categorised as a “immunosuppressant.” Rejection of organ transplants is avoided with its help. By preventing white blood cells, which are in charge of immunological responses, from acting in the body, it lowers immune system activity.
If you have an allergy to mycophenolate sodium or any immunosuppressive medications, avoid taking Ipca MMF-S Tablet. If you have liver or kidney disease, severe digestive problems, cancer, liver disease (such hepatitis B or hepatitis C), recent or past infections, or uncommon genetic disorders (like Lesch-Nyhan or Kelley-Seegmiller syndromes), let your doctor know before taking Ipca MMF-S Tablet. Ipca MMF-S Tablet is a pregnancy category risk D medication that can cause severe congenital problems in the foetus, so avoid using it if you are pregnant or intend to become pregnant. Breastfeeding moms shouldn’t use Ipca MMF-S Tablet since it gets into their breast milk.
During the course of treatment and for six weeks following the cessation of Ipca MMF-S Tablet, pregnant women should utilise effective birth control methods. Avoid interacting with anyone who have measles, shingles, or chickenpox while taking Ipca MMF-S Tablet. Because the Ipca MMF-S Tablet makes you drowsy and dizzy, drive carefully. Children shouldn’t be given Ipca MMF-S Tablets since its safety and effectiveness have not been shown. Avoid drinking alcohol while taking Ipca MMF-S Tablet as this may make you feel more lightheaded. To keep an eye on your health, your doctor can suggest routine blood, kidney, and liver testing. Wear protective clothes, use high-protection factor sunscreen, and avoid prolonged exposure to sunlight when using the Ipca MMF-S Tablet.
In Stock
Reviews
There are no reviews yet.